Newsbenzinga
BridgeBio Pharma Announces FDA Accepts For Filing Its New Drug Application For Encaleret To Treat Autosomal Dominant Hypocalcemia Type 1
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…